$ITRI

Itron (ITRI) officer to sell 283 vested shares

Itron (ITRI) officer Donald L. Reeves III plans to sell 283 shares, valued at $28,297.17, under Rule 144 on or after August 25, 2026. The shares stem from restricted stock vesting as compensation. Reeves has made several small sales of ITRI stock in the past three months.

Original reporting
Published Aug 25, 2026, 1:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ITRI
Neutral
medium confidence
Mentioned
$ITRI
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ITRINeutralLow
01

Why it matters

The disclosed sale adds marginal new supply; price impact expected to be negligible.

02

Market read

Routine insider sale with minimal market relevance; primarily of interest to ITRI shareholders.

03

What to watch

Potential future vesting events could increase insider sales; monitor cumulative insider activity.

Relevance 4/10Novelty 2/10Timing: sale scheduled on or after Aug 25, 2026

Background

Form 144 filing discloses a planned Rule 144 sale of restricted shares by an ITRI officer.

Company-level read

Ticker impact

$ITRINeutralMedium confidence
Context

Officer Donald L. Reeves III plans to sell 283 ITRI shares (≈$28k) under Rule 144 after Aug 25, 2026.

Expected impact

minimal downward pressure

Evidence & confidence

Sale size is small relative to float and market cap; typical for routine vesting.

Market effects

None; Itron operates in utility metering, but a tiny insider sale has no sector impact.

None; limited to ITRI shareholders.

Low; isolated company event.

Counterpoint

If the insider is signaling lack of confidence, some may view it as a bearish hint, but the amount is too small to be meaningful.

Key entities

  • Donald L. Reeves III

    Itron officer selling vested shares.

  • Fidelity Brokerage Services LLC

    Executing the Rule 144 transaction.

Related articles

$VIAVMed

Inspection Instruments Stocks Q2 Earnings Review: Keysight (NYSE:KEYS) Shines

Viavi Solutions (down 10.9%) had the fastest revenue growth among inspection instruments stocks, while Badger Meter (NYSE:BMI, down 9.3%) reported a 6.6% revenue decline. Itron (NASDAQ:ITRI, up 12.2%) missed revenue estimates but exceeded EBITDA and EPS guidance. Teledyne (NYSE:TDY, down 3.7%) reported a 9.8% revenue increase, beating expectations. Market risks have shifted from AI to geopolitics and back to fundamentals.

$ITRIMedAI 8/10

Why Shares of Itron Stock Jumped 17.4% This Week

Itron shares rose about 17% this week after the company reported strong Q2 results and raised full-year guidance, according to S&P Global Market Intelligence. Itron posted non-GAAP EPS of $1.59 versus $1.29 expected and cited demand for grid stability tied to AI infrastructure build-out. Full-year EPS guidance was raised to $6.40 at the midpoint.

$ITRIMed

Why Shares of Itron Stock Jumped 17.4% This Week

Itron (NASDAQ: ITRI) shares rose about 17.4% this week, after the utility technology company reported strong Q2 results and raised full-year guidance, according to S&P Global Market Intelligence. Non-GAAP EPS was $1.59 versus $1.29 expected. Full-year EPS guidance was raised to $6.40 at the midpoint.

$ITRIMedAI 8/10

Itron Q2 Earnings Call Highlights

Itron (NASDAQ:ITRI) reported Q2 GAAP net income of $53M, or $1.19/diluted share, versus $68M a year earlier. Non-GAAP operating income rose 8% to $89M and adjusted EBITDA rose 8% to $97M. Q2 revenue by segment: Device Solutions $111M, Networked Solutions $339M, Outcomes $96M, Resiliency Solutions about $16M. Free cash flow was $81M. Backlog was $4.4B. Itron raised full-year non-GAAP EPS to $6.30-$6.50 and narrowed revenue to $2.37B-$2.41B.